Please login to the form below
Probuphine
This page shows the latest Probuphine news and features for those working in and with pharma, biotech and healthcare.
FDA gives green light for opioid addiction implant
FDA gives green light for opioid addiction implant. Titan and Braeburn's Probuphine is first implant of its kind to win US approval. ... It found that 63% of patients treated with the Probuphine implant had no evidence of illicit opioid use throughout
Latest news
-
FDA panel backs approval of first opioid addiction implant
FDA panel backs approval of first opioid addiction implant. Probuphine has been developed by Titan Pharma and partner Braeburn Pharma. ... At the committee meeting, Braeburn presented summary safety findings with a particular focus on the Probuphine
More from news
Approximately 2 fully matching, plus 0 partially matching documents found.
Featured jobs
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
-
Account Manager
-
£40, 000 - £45, 000 benefits
- Home based, Senior Medical Writer, Medical Communications
-
Excellent package
-
Client Services Director - Med Comms
-
Great salary and bebefits
- Home based, Principal Medical Writer, Medical Communications
-
Excellent package
-
Healthcare PR Director
-
£100, 000 – £120, 000 benefits
- Account Director, Medical Communications
-
C£50 – 65, 000 benefits and bonus
- Home based, Editorial Team Leader, Medical Communications
-
Excellent package
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
- Strategic Planner, Healthcare Advertising
-
£47, 000 – £53, 000
- Home based, Chief Medical Writer, Medical Communications
-
Excellent package
- Business Unit Head, Medical Communications, London
-
Excellent package
- Account Director, Consumer Healthcare PR, Global PR agency
-
£50, 000 – £58, 000
- Head of Market Access - International - Based Cambridge
-
Excellent Basic, Bonus and Flex Benefits
Subscribe to our email news alerts
- Brexit rebels win vote on European Medicines Agency alignment
- AstraZeneca joins Merck in Brexit stockpiling effort
- NHS England to Vertex: come clean on Orkambi offer
- Moving annual total (MAT)
- Vyriad inks immunotherapy alliance with Merck/Pfizer
- J&J’s Invokana aces diabetic kidney disease trial, setting up filings
- NHS England to Vertex: come clean on Orkambi offer
- Sangamo bulks up in cell therapy with TxCell acquisition
- Random42 win Creativity International Award for Scientific Animation
- Merck & Co joins big pharma pricing pledge – but sceptics unconvinced
- Aurora partners with PIPHealth and taps into patient panels
- FDA’s Gottlieb lambasts industry’s biosimilar-blocking tactics
PMHub
GEM Marketing Ltd
GEM, a small but perfectly formed integrated marketing agency servicing the pharmaceutical industry....
Latest intelligence
- Developing advocacy in the pharmaceutical industry.
- The importance of advocacy programmes...
- GDPR and events. What does the pharma industry need to know?
- Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
- Digital trends in B2B sales - how far behind is Pharma?
- The modern approach to B2B sales is data-driven, and enabled by digital tools....
Quick links
Infographics
